Bolt Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.89

-0.02 (-0.38%)

As of Jun 30, 4:36 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +577.9% upside

Low Target $21.16

Average Target $26.37

High Target $30.50

Current Price $3.89

Current
$3.89

Target
$26.37

$21.16 $26.37 avg $30.50

Scenario Analysis

Bear Case

$21.16

444.0%

Low target

Base Case

$26.37

+577.9%

Avg target

Bull Case

$30.50

+684.1%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$7.20

-46.0% from high

52-Week Low

$3.75

+3.7% from low

Target vs 52W High

$26.37

+266.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%